134 related articles for article (PubMed ID: 10794412)
1. Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.
Cook WJ; DeLucas LJ; Chattopadhyay D
Protein Sci; 2000 Apr; 9(4):704-12. PubMed ID: 10794412
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
J Mol Biol; 2000 Feb; 296(2):549-67. PubMed ID: 10669608
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
J Mol Biol; 2000 May; 298(5):875-93. PubMed ID: 10801355
[TBL] [Abstract][Full Text] [Related]
4. Structure of Toxoplasma gondii adenosine kinase in complex with an ATP analog at 1.1 angstroms resolution.
Zhang Y; El Kouni MH; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):140-5. PubMed ID: 16421444
[TBL] [Abstract][Full Text] [Related]
5. Substrate analogs induce an intermediate conformational change in Toxoplasma gondii adenosine kinase.
Zhang Y; El Kouni MH; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2007 Feb; 63(Pt 2):126-34. PubMed ID: 17242506
[TBL] [Abstract][Full Text] [Related]
6. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
el Kouni MH
Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
Yadav V; Chu CK; Rais RH; Al Safarjalani ON; Guarcello V; Naguib FN; el Kouni MH
J Med Chem; 2004 Apr; 47(8):1987-96. PubMed ID: 15055998
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii adenosine kinase: expression, purification, characterization, crystallization and preliminary crystallographic analysis.
Recacha R; Talalaev A; DeLucas LJ; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2000 Jan; 56(Pt 1):76-8. PubMed ID: 10666633
[TBL] [Abstract][Full Text] [Related]
9. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
[TBL] [Abstract][Full Text] [Related]
11. Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase.
Darling JA; Sullivan WJ; Carter D; Ullman B; Roos DS
Mol Biochem Parasitol; 1999 Sep; 103(1):15-23. PubMed ID: 10514077
[TBL] [Abstract][Full Text] [Related]
12. 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Rais RH; Al Safarjalani ON; Yadav V; Guarcello V; Kirk M; Chu CK; Naguib FN; el Kouni MH
Biochem Pharmacol; 2005 May; 69(10):1409-19. PubMed ID: 15857605
[TBL] [Abstract][Full Text] [Related]
13. Structure of human adenosine kinase at 1.5 A resolution.
Mathews II; Erion MD; Ealick SE
Biochemistry; 1998 Nov; 37(45):15607-20. PubMed ID: 9843365
[TBL] [Abstract][Full Text] [Related]
14. Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii.
Chaudhary K; Darling JA; Fohl LM; Sullivan WJ; Donald RG; Pfefferkorn ER; Ullman B; Roos DS
J Biol Chem; 2004 Jul; 279(30):31221-7. PubMed ID: 15140885
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter.
Schwab JC; Afifi Afifi M; Pizzorno G; Handschumacher RE; Joiner KA
Mol Biochem Parasitol; 1995 Mar; 70(1-2):59-69. PubMed ID: 7637715
[TBL] [Abstract][Full Text] [Related]
16. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
[TBL] [Abstract][Full Text] [Related]
17. Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.
Naguib FN; Rais RH; Al Safarjalani ON; el Kouni MH
Comp Biochem Physiol B Biochem Mol Biol; 2015 Oct; 188():63-9. PubMed ID: 26112826
[TBL] [Abstract][Full Text] [Related]
18. Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus.
Sullivan WJ; Chiang CW; Wilson CM; Naguib FN; el Kouni MH; Donald RG; Roos DS
Mol Biochem Parasitol; 1999 Sep; 103(1):1-14. PubMed ID: 10514076
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.
Iltzsch MH; Uber SS; Tankersley KO; el Kouni MH
Biochem Pharmacol; 1995 May; 49(10):1501-12. PubMed ID: 7763293
[TBL] [Abstract][Full Text] [Related]
20. Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; El Kouni MH
Biochem Pharmacol; 2010 Oct; 80(7):955-63. PubMed ID: 20541538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
